Chad Cowan Century Therapeutics, Inc. (IPSC) insider trading activity

IPSC Quotes by TradingView

Chad Cowan is Chief Scientific Officer of Century Therapeutics, Inc.. Currently has a direct ownership of 230,306 shares of IPSC, which is worth approximately $126,668. The most recent transaction as insider was on Mar 11, 2025, when has been sold 19,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 230K
9.25% 3M change
n/a 12M change
Total Value Held $126,668

Chad Cowan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 11 2025
BUY
Grant, award, or other acquisition
-
19,500 Added 7.81%
230,306 Common Stock
Oct 01 2024
BUY
Grant, award, or other acquisition
-
74,376 Added 26.08%
210,806 Common Stock
CC

Chad Cowan

Chief Scientific Officer
Philadelphia, PA

Track Institutional and Insider Activities on IPSC

Follow Century Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IPSC shares.

Notify only if

Insider Trading

Get notified when an Century Therapeutics, Inc. insider buys or sells IPSC shares.

Notify only if

News

Receive news related to Century Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IPSC